|
- Innovation - Amgen
Amgen scientists are transforming the biopharmaceutical landscape through combining innovative, single-use technologies, thereby improving productivity and efficiency in manufacturing biologics
- Amgen 2025: The future of American science and innovation
A robust investment in manufacturing capabilities and a strong pipeline of products in its four therapeutic categories is preparing Amgen for the next era of scientific discovery to advance medicines that will improve human health
- Amgen Drives U. S. Manufacturing Leadership - This is Innovation.
By investing in American manufacturing, Amgen is bringing home the innovative work of discovering new medicines for years to come See how Amgen is investing in innovation, workforce development and the community in Central Ohio
- Amgen Inc. s Strategic Expansion and Innovation: A Resilient . . .
- Amgen invests $1 5B in North Carolina, boosting sustainable manufacturing and creating 370 jobs to meet global demand for therapies - Leverages AI and data science in R D, focusing on biosimilars and niche treatments for rare diseases to drive innovation and cost-effective care
- Amgen to Invest $600 Million in New State-of-the-Art Center . . .
On Sept 2, 2025, Amgen announced plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California
- Amgen to Bolster U. S. Innovation with Over $600 Million . . .
At Amgen, we’re continuing to invest in the future of American science and innovation This new center will empower our scientists with the tools and collaborative environment they need to shape the next era of scientific discovery and advance medicines that improve human health
- AMGEN INVESTING MORE THAN HALF A BILLION DOLLARS IN NEW . . .
More than 40 years ago, Amgen helped to establish the biotechnology industry and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what's known today
|
|
|